Targeting the $5 BILLION Soft Tissue Repair Market

Chitogenx is in the regulatory lead for regenerative products + signs MOU with major Medical Institute

Free
Message: SmallCap 60: Ortho Regenerative Technologies (ORTH: CSE) (ORTIF: OTCQB) New Patent To Protect Core IP Until 2035
Reply New Message
Back To Forum List View

SmallCap 60: Ortho Regenerative Technologies (ORTH: CSE) (ORTIF: OTCQB) New Patent To Protect Core IP Until 2035

posted on May 19, 2022 05:12PM
Log in to use the IP Check tool [?]

Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply